National Advertising Division Refers Health-Related Advertising Claims for Prolacta’s Human Milk Fortifier to Regulatory Agencies
New York, NY – July 15, 2024 – BBB National Programs’ National Advertising Division will refer advertising claims made by Prolacta Bioscience, Inc. for its Human Milk Fortifier to the Federal Trade Commission (FTC) and Food and Drug Administration (FDA) for review. The referral was made after Prolacta declined to participate in the industry self-regulation process.
Mead Johnson & Company, LLC challenged Prolacta’s claims that its human milk-based fortifier products have been shown in clinical studies to be more effective at improving health outcomes in premature infants as compared to cow milk-based fortifier products.
Express Claims
- Claim that “Compared to cow milk-based fortifiers, an Exclusive Human Milk Diet (EHMD) with Prolacta's 100% human milk-based nutritional products has been clinically proven in multiple clinical studies to” produce certain health benefits.
- “When used as part of an exclusive human milk diet (EHMD), Prolacta’s nutritional products are clinically proven to improve health outcomes and reduce hospital costs for critically ill, extremely premature infants as compared to cow milk-based fortifier…”
- “When used as part of an EHMD, our nutritional products are clinically proven to increase survival and reduce the overall cost of care compared to cow milk–based fortifiers . . . in extremely premature infants.”
- “Prolacta products used as a part of that EHMD, as compared to cow milk–based fortifiers, have been shown in clinical studies to benefit critically ill, premature infants in the NICU weighing ≤1250g at birth in many ways…”
Implied Claims
- Prolacta’s HMF products have been proven through rigorous scientific testing to provide better health outcomes than all cow milk-based HMFs, including those manufactured by Mead Johnson.
Prolacta declined to substantively respond to the challenge. Due to Prolacta’s decision to not participate in the NAD self-regulatory process for these claims, NAD will refer the matter to the FTC and FDA for review and possible enforcement action.
All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB procedures, this release shall not be used for advertising or promotional purposes.
Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.
In National Advertising Division Fast-Track SWIFT Case, SharkNinja Voluntarily Modifies Disclosure for “500x Less Dust Exposure” Claim
New York, NY – August 21, 2024 – The National Advertising Division has closed a Fast-Track SWIFT challenge initiated by Dyson regarding advertising by SharkNinja for its Shark Clean & Empty Cordless Stick Vacuum & Auto-Empty System.
National Advertising Division Recommends Happy Mammoth Discontinue Certain Health-Related Claims for Hormone Harmony Dietary Supplement
National Advertising Division Recommends Datarails Disclose Material Connection to The Finance Weekly Website for Endorsement, Rankings, and Reviews
New York, NY – August 16, 2024 – In a Fast-Track SWIFT challenge, the National Advertising Division recommended that Datarails clearly and conspicuously disclose its material connection to The Finance Weekly website where endorsement, rankings, and reviews appear.
National Advertising Division Finds Certain Claims for Online Corporate Formation Services Supported; Recommends LegalZoom Modify or Discontinue Others
New York, NY – August 15, 2024 – In a challenge brought by ZenBusiness, the National Advertising Division determined that LegalZoom provided a reasonable basis for certain claims regarding its online corporate formation services but recommended that it discontinue or modify others.